π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
To provide elotuzumab treatment for single-patient use....
Status
No Longer Available
Location
Icahn School.of Medicine at Mount Sinai
Start Date
TBD
Trial ID
NCT02541643
Treatments Being Tested
The purpose of this study is to determine the efficacy of Lenalidomide/Dexa...
Status
Completed
Location
Local Institution
Start Date
2015-02-20
Trial ID
NCT02272803
Treatments Being Tested
To assess the safety and tolerability, characterize the dose limiting toxic...
Status
Completed
Location
University Of Arkansas For Medical Sciences
Start Date
2014-12-09
Trial ID
NCT02252263
Treatments Being Tested
To explore whether Elotuzumab dose administration over approximately 60 min...
Status
Completed
Location
Acrc/Arizona Clinical Research Center, Inc.
Start Date
2014-03-08
Trial ID
NCT02159365
Treatments Being Tested
This phase Ib trial tests the safety, side effects, and best dose of CC-924...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2023-12-21
Trial ID
NCT05981209
The purpose of the study is to determine whether the addition of Elotuzumab...
Status
Completed
Location
Compassionate Cancer Res Grp
Start Date
2011-11-30
Trial ID
NCT01478048
Treatments Being Tested
This is a two-part multi-center clinical trial in participants with active ...
Status
Terminated
Location
Emory Healthcare
Start Date
2021-10-13
Trial ID
NCT04918147
The objective of this expanded access program is to provide treatment with ...
Status
No Longer Available
Location
Local Institution
Start Date
TBD
Trial ID
NCT02856438
Treatments Being Tested
The purpose of this study is determine Time-to-Progression with elotuzumab ...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2018-10-04
Trial ID
NCT03411031
Treatments Being Tested
This phase II trial studies how well elotuzumab works when given with lenal...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2015-04-14
Trial ID
NCT02420860
Treatments Being Tested